STERIS (STE) VP John P. Ubbing details insider shares and options

Rhea-AI Filing Summary

STERIS plc executive John P. Ubbing, Vice President, Chief Compliance & Quality Officer, reports his beneficial ownership in the company as of early 2026. He directly holds 4,230 ordinary shares, of which 2,952 are restricted. These restrictions are scheduled to lapse in stages: 660 shares on May 31, 2026; 1,128 shares on June 2, 2026; 588 shares on June 4, 2027; and 576 shares on June 3, 2028.

In addition, Ubbing has an indirect interest in 248 ordinary share equivalents held for him under the STERIS Corporation 401(k) Plan. He also holds several employee stock options: 2,480 options at an exercise price of $219.97 expiring May 31, 2033; 2,008 options at $251.34 expiring June 4, 2034; and 2,056 options at $267.66 expiring June 3, 2035, each with multi-year vesting schedules that gradually become exercisable.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

McGowan Lindsey

(Last) (First) (Middle)

70 SIR JOHN ROGERSON'S QUAY

(Street)

DUBLIN 2 L2 D02 R296

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2026

3. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Chf. Comp. & Quality Offc.

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	4,230(1)	D
Ordinary Shares	248	I	See Footnote Below(2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	(3)	05/31/2033	Ordinary Shares	2,480	$219.97	D
Employee Stock Option (right to buy)	(4)	06/04/2034	Ordinary Shares	2,008	$251.34	D
Employee Stock Option (right to buy)	(5)	06/03/2035	Ordinary Shares	2,056	$267.66	D

Explanation of Responses:

1. As of January 1, 2026, 2,952 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 660 on May 31, 2026; 1,128 on June 2, 2026; 588 on June 4, 2027 and 576 on June 3, 2028.

2. Units representing 248 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of January 2, 2026.

3. 1,240 of these options are exercisable. This option becomes exercisable as follows: 620 on June 1, 2026 and 620 on May 31, 2027.

4. 502 of these options are exercisable. This option becomes exercisable as follows: 502 on June 4, 2026; 502 on June 4, 2027 and 502 on June 5, 2028.

5. This option becomes exercisable as follows: 514 on June 3, 2026; 514 on June 3, 2027; 514 on June 5, 2028 and 514 on June 4, 2029.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ John P. Ubbing, Authorized Representative under Power of Attorney	01/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider position is disclosed for STERIS plc (STE)?

The filing discloses the holdings of John P. Ubbing, who serves as Vice President, Chief Compliance & Quality Officer of STERIS plc.

How many STERIS plc ordinary shares does John P. Ubbing own?

He directly owns 4,230 ordinary shares, and 2,952 of these are noted as restricted shares subject to time-based vesting.

When do John P. Ubbing’s restricted STERIS shares vest?

The restrictions lapse on 660 shares May 31, 2026; 1,128 shares June 2, 2026; 588 shares June 4, 2027; and 576 shares June 3, 2028.

What indirect STERIS holdings does John P. Ubbing report?

He reports units representing 248 ordinary share equivalents held on his behalf under the STERIS Corporation 401(k) Plan as of January 2, 2026.

What STERIS employee stock options does John P. Ubbing hold?

He holds options for 2,480 ordinary shares at $219.97 expiring May 31, 2033; 2,008 shares at $251.34 expiring June 4, 2034; and 2,056 shares at $267.66 expiring June 3, 2035.

How many of John P. Ubbing’s STERIS options are currently exercisable?

The filing notes that 1,240 options from the May 31, 2033 grant and 502 options from the June 4, 2034 grant are exercisable, with additional tranches scheduled to vest in future years.